Azre Reinsurance
Presence
AstraZeneca is one of the...
- Forbes Global 2000 (#126);
- Fortune 500 Europe (#78);
- FTSE 350;
- Global Fortune 500 (#331);
- Nasdaq 100;
- Stoxx 600.
AstraZeneca is a company listed under the stock ticker AZN (GB).
AstraZeneca has a direct presence in 31 countries.AstraZeneca has 42 subsidiaries including Alexion Pharma Europe, Alexion Pharma France and Alexion Pharma Ireland.
They are in:
- Pharmaceuticals88%
- Biotechnology9%
- Other2%
Acquisition, funding and merger involving AstraZeneca.
- AstraZeneca has announced the acquisition of Fusion Pharma (posted on March 23 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (posted on March 19 2024).
- AstraZeneca has acquired Gracell Biotechnologies (posted on February 23 2024).
- AstraZeneca has acquired CinCor Pharma (posted on January 10 2023).
- AstraZeneca has announced the acquisition of Neogene Therapeutics (posted on November 29 2022).
- See more news about AstraZeneca Hide news involving AstraZeneca
Executives
View the org chart displaying its 8 main executives
Most searched biographies at Azre Reinsurance
- Vusal Abbasov, Chairman of the Management Board
- Valihad Safarov, Member of the Supervisory Board
- Tokay Alizada, Chairman of the Supervisory Board
Create your alert
to follow the executive moves at Azre Reinsurance.
Reinsurance
AstraZeneca has 388 competitors including Swiss Re (Switzerland), Amwins Global Risks (United Kingdom (UK)) and Everest Reinsurance (Bermuda).
Popular M&A news in Reinsurance
- Fleming Insurance has acquired JRG Reinsurance (posted on April 22 2024).
- Brookfield Reinsurance has acquired Argo Group (posted on November 17 2023).
- RenaissanceRe has acquired Validus Reinsurance (posted on November 16 2023).
Popular contacts in Reinsurance
News
Press releases by Azre Reinsurance
Social media about Azre Reinsurance
- Azre Reinsurance on Wikipedia, Google News & Yahoo Finance
- Azre Reinsurance on LinkedIn, Twitter & YouTube
